Laurus Labs Ratios

Laurus Labs Ltd Ratios

The Laurus Labs Ltd Ratios page provides a complete fundamental analysis of Laurus Labs Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Laurus Labs Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Laurus Labs Ltd (NSE: LAURUSLABS, BSE: 540222) is currently trading at ₹1075.80, with a market capitalization of ₹580.21B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Laurus Labs Ltd remains a key stock for fundamental analysis using Laurus Labs Ltd Ratios.

Laurus Labs Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Laurus Labs Ltd P/E ratio currently stands at 92.43, making it one of the most tracked metrics in Laurus Labs Ltd Ratios.

Historically, the Laurus Labs Ltd P/E ratio has shown strong fluctuations:

• 2024: 92.43
• 2023: 131.68
• 2022: 20.01
• 2021: 38.44
• 2020: 19.81

The decline in Laurus Labs Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Laurus Labs Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 7.40.

Historical P/B trend:

• 2024: 7.40
• 2023: 5.14
• 2022: 3.91
• 2021: 9.46

Laurus Labs Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Laurus Labs Ltd P/S ratio currently stands at 5.96, an important part of Laurus Labs Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 5.96
• 2023: 4.19
• 2022: 2.62
• 2021: 6.45

The rising Laurus Labs Ltd P/S ratio indicates improved revenue valuation by investors.

Laurus Labs Ltd Price to Cash Flow Ratio (P/CF)

The Laurus Labs Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 83.10.

Historical Laurus Labs Ltd Price to Cash Flow Ratio:

• 2024: 83.10
• 2023: 42.54
• 2022: 18.43
• 2021: 38.43
• 2020: 28.81

The rising Laurus Labs Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Laurus Labs Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Laurus Labs Ltd EV currently stands at ₹358.7B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 358.7B
• 2023: 235.82B
• 2022: 177.88B
• 2021: 335.22B

Laurus Labs Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Laurus Labs Ltd EV/EBITDA ratio is currently 33.10, a key metric in Laurus Labs Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 33.10
• 2023: 29.33
• 2022: 10.86
• 2021: 23.28

Higher Laurus Labs Ltd EV/EBITDA suggests premium valuation.

Laurus Labs Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Laurus Labs Ltd D/E ratio is currently 0.62, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.62
• 2023: 0.63
• 2022: 0.50
• 2021: 0.53

Laurus Labs Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Laurus Labs Ltd ROE currently stands at 8.35%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 8.35
• 2023: 3.94
• 2022: 21.39
• 2021: 27.82

Declining ROE indicates pressure on profitability.

Laurus Labs Ltd Ratios Analysis Summary

The Laurus Labs Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Laurus Labs Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Laurus Labs Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.